Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
TPP Multinational Policy Arguments Mimic False Claims Made for Past Pacts as Use of Perennial Trade Deal Sales-Pitch-of-Last-Resort Increases April 10, 2014
Senior House Democrats Letter to President Obama on Multinational Investor Privileges in the TPP December 15, 2010